Hypertension
Hypertension
Aliskiren - Clinical Benefits in the Management of Hypertension - Aliskiren is the first orally effective direct renin inhibitor (DRI), and has recently been approved by the US Food and Drug Administration (FDA) and the European Medicines Agency (EMEA) for the treatment of hypertension.
Editor's Choice
Cardiovascular disorders (CVDs) remain the leading cause of death and disability in the US and the rest of the world. Population, physiological and clinical studies have demonstrated that numerous...
Arterial hypertension is a slow killer. A severe coarctation presenting in the neonatal period is frequently associated with hypoplasia of the aortic arch, which is proof of earlier poor foetal...
Latest News
11th November 2008 -
Past Gains in Reducing Risk of Heart Disease Have Flattened; Women Especially Affected
20th October 2008 -
New Book Extols Benefits Of Chocolate
Medical Guidelines
To examine new evidence on the association of lipid abnormalities with early atherosclerosis and highlight results of clinical trials with statin therapy in children & adolescents with familial...
To assist physicians in clinical decision-making by providing well-balanced information on the management of patients with hypertension, without restricting the physician's individual judgment. ...
